Search - tctmd.com

Displaying 61 - 80 of 532

Sort: Relevancy | Date

News Daily News

Early Invasive Intervention Trumps Delayed Approach in NSTEMI Patients

Michael O'Riordan

January 20, 2016

News Daily News

Expert Consensus Highlights Needs of Cancer Patients in the Cath Lab and Beyond

L.A. McKeown

January 12, 2016

News Daily News

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Yael L. Maxwell

January 05, 2016

News Daily News

La Duración de los Síntomas Podría ser Más Importante que el Tiempo Puerta-Balón en el Manejo de Los Cuadros de STEMI, según un Subestudio del HORIZONS-AMI

Yael L. Maxwell

January 05, 2016

News Daily News

HORIZONS-AMI 亚组研究表明，STEMI 患者的症状持续时间可能比 D2B 更重要

Yael L. Maxwell

January 05, 2016

News Daily News

CvLPRIT Substudy Finds Little Lasting Damage From Non-Infarct Artery PCI

Caitlin E. Cox

December 15, 2015

News Industry News

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

December 08, 2015

News Daily News

Troponin, BNP Tests Key to Reducing Perioperative Cardiac Complications After Noncardiac Surgery

L.A. McKeown

December 02, 2015

News Daily News

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

Todd Neale

November 16, 2015

News Featured Fellow

Benjamin Z. Galper, MD, MPH

Yael L. Maxwell

November 15, 2015

News Conference News AHA 2015

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

Todd Neale

November 10, 2015

News Daily News

COURAGE at 15 Years: Still No Survival Advantage for PCI

L.A. McKeown

November 10, 2015

News Conference News AHA 2015

RIVER-PCI Subanalysis: No Impact of Ranolazine on Quality of Life

L.A. McKeown

November 09, 2015

News Conference News AHA 2015

IVUS Tops Angiography for Guiding DES Implantation in Long Lesions

Todd Neale

November 09, 2015

News Conference News AHA 2015

DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year

Yael L. Maxwell

November 09, 2015

News Industry News

Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure

October 27, 2015

News Daily News

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

L.A. McKeown

October 26, 2015

News Industry News

One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015

October 20, 2015

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? For Limb Ischemia There Are Knowns and Unknowns!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Amit Patel

October 15, 2015

News Industry News

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

October 15, 2015

Advertisement

Early Invasive Intervention Trumps Delayed Approach in NSTEMI Patients

Expert Consensus Highlights Needs of Cancer Patients in the Cath Lab and Beyond

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

La Duración de los Síntomas Podría ser Más Importante que el Tiempo Puerta-Balón en el Manejo de Los Cuadros de STEMI, según un Subestudio del HORIZONS-AMI

HORIZONS-AMI 亚组研究表明，STEMI 患者的症状持续时间可能比 D2B 更重要

CvLPRIT Substudy Finds Little Lasting Damage From Non-Infarct Artery PCI

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

Troponin, BNP Tests Key to Reducing Perioperative Cardiac Complications After Noncardiac Surgery

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

Benjamin Z. Galper, MD, MPH

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

COURAGE at 15 Years: Still No Survival Advantage for PCI

RIVER-PCI Subanalysis: No Impact of Ranolazine on Quality of Life

IVUS Tops Angiography for Guiding DES Implantation in Long Lesions

DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year

Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015

Debate: Are We Really Ready for Phase III Trials? For Limb Ischemia There Are Knowns and Unknowns!

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content